What are the recommended treatment options for nail psoriasis?

Treatment for Nail Psoriasis

For nail psoriasis, biologics targeting IL-17 (ixekizumab, secukinumab, brodalumab) are the most effective treatments and should be prioritized for moderate-to-severe disease or when more than 3 nails are affected. 1

Treatment Algorithm Based on Disease Extent

Few-Nail Disease (≤3 nails affected)

For matrix involvement:

• Intralesional corticosteroid injections are the treatment of choice 2
• This approach directly targets the inflammatory process at the nail matrix where pitting and other changes originate

For nail bed involvement only:

• Topical corticosteroids alone or combined with topical vitamin D analogues (calcipotriol) 2
• Preferred formulations: ointments, solutions, or foams for better penetration 3

Many-Nail Disease (>3 nails affected)

Systemic therapy is indicated when:

• More than 3 nails are involved
• Significant quality of life impairment exists
• Coexisting moderate-to-severe skin psoriasis is present
• Psoriatic arthritis is present 2, 3

Systemic Treatment Hierarchy

First-Line Biologics (Highest Efficacy)

IL-17 Inhibitors - Superior Short-Term Efficacy 4

Ixekizumab (Strength of Recommendation: B) 1

• Dosing: 160 mg subcutaneous injection at week 0, then 80 mg at weeks 2,4,6,8,10, and 12
• Maintenance: 80 mg every 4 weeks (some patients may require every 2 weeks)
• Evidence: At week 20,63.8% improvement in NAPSI score; by week 48,51% achieved complete nail clearance (NAPSI = 0) 1

Secukinumab 1

• Effective for nail psoriasis with demonstrated efficacy in RCTs
• Dosing: 300 mg preferred over 150 mg for nail disease
• Maintenance: 300 mg every 4 weeks after initial 12-week loading

Brodalumab 1

• Effective for nail, scalp, erythrodermic, and generalized pustular psoriasis
• Blocks IL-17 receptor A
• Caution: Avoid in patients with active or history of inflammatory bowel disease due to risk of reactivation

Alternative Biologics

TNF-α Inhibitors 1, 4

Adalimumab (Strength of Recommendation: I-II evidence) 1

• Dosing: 80 mg week 1, then 40 mg week 2, then 40 mg every 2 weeks
• Effective for nail psoriasis demonstrated in multiple clinical studies
• Can be combined with topical corticosteroids, vitamin D analogues, or acitretin for enhanced efficacy 1

IL-23 Inhibitors 4

• Similar long-term efficacy to TNF-α inhibitors
• Comparable efficacy to TNF-α inhibitors for nail psoriasis specifically

Conventional Systemic Agents

When biologics are not accessible or appropriate 2:

• Methotrexate - low strength of evidence 5
• Cyclosporine - low strength of evidence 5
• Acitretin - low strength of evidence, frequently combined with adalimumab for palmoplantar involvement 1, 5

Small Molecules

Apremilast and JAK inhibitors 6, 2, 5

• Low strength of evidence
• May be considered as alternative options

Key Clinical Considerations

Comparative Efficacy:

• IL-17 inhibitors demonstrate superior short-term efficacy compared to IL-23 and TNF-α inhibitors 4
• Long-term efficacy of IL-17 inhibitors is similar to TNF-α inhibitors 4
• IL-23 and TNF-α inhibitors have similar efficacy profiles for nail psoriasis 4

Treatment Response Timeline:

• Nail psoriasis is notoriously slow to respond - treatment is "extremely protracted" 7
• Expect 20-48 weeks for significant improvement with biologics 1
• Nail growth rate limits speed of visible improvement

Common Pitfalls:

• Undertreating nail psoriasis despite significant quality of life impact 7
• Failing to recognize that nail severity doesn't parallel skin disease severity 2
• Not screening for psoriatic arthritis - nail psoriasis is strongly associated with joint involvement 8, 7
• Missing coexisting onychomycosis, which should always be ruled out 7

Combination Therapy:

• Biologics can be safely combined with topical therapies, though published data are limited 1
• Adalimumab specifically has evidence supporting combination with topicals and acitretin 1

Prophylactic Measures:

• General nail care and protective measures should be recommended for all patients 3